Growth Metrics

InspireMD (NSPR) Accumulated Depreciation & Amortization (2016 - 2025)

InspireMD's Accumulated Depreciation & Amortization history spans 13 years, with the latest figure at $476.0 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 70.0% year-over-year to $476.0 million; the TTM value through Dec 2025 reached $476.0 million, up 70.0%, while the annual FY2025 figure was $476.0 million, 70.0% up from the prior year.
  • Accumulated Depreciation & Amortization reached $476.0 million in Q4 2025 per NSPR's latest filing, up from $280.0 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $476.0 million in Q4 2025 to a low of $1.7 million in Q4 2021.
  • Average Accumulated Depreciation & Amortization over 5 years is $235.5 million, with a median of $232.0 million recorded in 2023.
  • Peak YoY movement for Accumulated Depreciation & Amortization: soared 10779.63% in 2022, then grew 20.69% in 2024.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $1.7 million in 2021, then surged by 10779.63% to $188.0 million in 2022, then increased by 23.4% to $232.0 million in 2023, then grew by 20.69% to $280.0 million in 2024, then skyrocketed by 70.0% to $476.0 million in 2025.
  • Per Business Quant, the three most recent readings for NSPR's Accumulated Depreciation & Amortization are $476.0 million (Q4 2025), $280.0 million (Q4 2024), and $232.0 million (Q4 2023).